CHIESI PHARMACEUTICALS
Chiesi Pharmaceuticals provides research, development, production, and marketing of medicines for respiratory, neonatology, rare diseases. It was established in 1935 and is based in Parma, Emilia-Romagna.
CHIESI PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1935-01-01
Address:
Parma, Emilia-Romagna, Italy
Country:
Italy
Website Url:
http://www.chiesi.com
Total Employee:
5001+
Status:
Active
Contact:
39 05 212791
Technology used in webpage:
Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag Mobile Non Scaleable Content Nginx Google Maps
Similar Organizations
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Alberto Chiesi Chairman @ Chiesi Pharmaceuticals
Chairman
Stefano Accorsi Head of Regulatory Affairs "Rest of the World" @ Chiesi Pharmaceuticals
Head of Regulatory Affairs "Rest of the World"
Ugo Di Francesco Group CEO @ Chiesi Pharmaceuticals
Group CEO
2011-10-01
Diego Ardigò Global Rare Diseases, Research & Development Head @ Chiesi Pharmaceuticals
Global Rare Diseases, Research & Development Head
2020-02-01
Paolo Chiesi Vice Chairman @ Chiesi Pharmaceuticals
Vice Chairman
Danilo Piroli Director @ Chiesi Pharmaceuticals
Director
Sara Panigone Project Leader @ Chiesi Pharmaceuticals
Project Leader
2019-12-01
Raffaella Monno Head of Real World Evidence, R&D Global Clinical Development @ Chiesi Pharmaceuticals
Head of Real World Evidence, R&D Global Clinical Development
2020-06-01
Alberto D'Avino Senior Manager, Regulatory CMC @ Chiesi Pharmaceuticals
Senior Manager, Regulatory CMC
2021-04-01
Charles Potter Project Leader and Technical Leader @ Chiesi Pharmaceuticals
Project Leader and Technical Leader
2019-09-01
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-11-21 | Atopix Therapeutics | Atopix Therapeutics acquired by Chiesi Pharmaceuticals | N/A |
| 2014-02-04 | Cornerstone Therapeutics | Cornerstone Therapeutics acquired by Chiesi Pharmaceuticals | N/A |
| 2013-08-26 | Zymenex | Zymenex acquired by Chiesi Pharmaceuticals | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-06-24 | Cyclica | Chiesi Pharmaceuticals investment in Series B - Cyclica | 23 M CAD |
| 2013-07-09 | UniQure | Chiesi Pharmaceuticals investment in Private Equity Round - UniQure | 58 M USD |
| 2012-07-02 | Cornerstone Therapeutics | Chiesi Pharmaceuticals investment in Post-IPO Debt - Cornerstone Therapeutics | 30 M USD |
Official Site Inspections
http://www.chiesi.com Semrush global rank: 500.39 K Semrush visits lastest month: 99.43 K
- Host name: nu000715.arubabiz.net
- IP address: 195.231.74.56
- Location: Ponte San Pietro Italy
- Latitude: 45.7059
- Longitude: 9.5872
- Timezone: Europe/Rome
- Postal: 24036
More informations about "Chiesi Pharmaceuticals"
Management | Chiesi Farmaceutici S.p.A.
The management of Chiesi Farmaceutici S.p.A. VAT IT 01513360345 Company's Capital: Euro 75.000.000 Companies Register Office - Parma N.15739See details»
About us - Our company - Chiesi
The Chiesi Foundation. The Chiesi Foundation was founded in 2005 as a nonprofit organization that aims to promote health and to ease the suffering of patients through research, knowledge …See details»
Benefit Corporation and B Corp - Chiesi Farmaceutici
B Corp certification, issued by the non-profit organization B Lab, is a voluntary certification that recognizes companies demonstrating a high level of social and environmental impact and provides a robust framework for evaluation. With …See details»
Chiesi Pharma - Globally
The Chiesi Foundation Onlus was founded in 2005 and is an ideal organization aimed at promoting human health and relieving patients' suffering through research, knowledge sharing …See details»
Chiesi Global Rare Diseases | A Rare Disease …
At Chiesi, we are making a rare difference. We strive to create a world where it is common to have a therapy for all diseases and we act as a force for good, for society and the planet. As a …See details»
Chiesi Farmaceutici - Wikipedia
Chiesi Farmaceutici S.p.A. is an Italian family controlled [1] [2] global pharmaceutical company based in Parma, Emilia-Romagna.Chiesi has 31 affiliates [3] in the world, nearly 6,500 total …See details»
About us - chiesi
About Chiesi Group. Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and …See details»
Chiesi - one of the world's leading pharmaceutical companies
Chiesi Foundation Onlus. The Chiesi Foundation Onlus was founded in 2005 and is an ideal organization aimed at promoting human health and relieving patients' suffering through …See details»
CHIESI USA
Today Chiesi is still very much a family-led organization that embraces its entrepreneurial roots. The company continually strives to not only develop innovative solutions for its current …See details»
Chiesi Farmaceutici - Crunchbase Company Profile & Funding
A system for monitoring and evaluating the safety of Chiesi's marketed and clinical development products, ensuring patient safety and compliance with regulations. Medical Information: A …See details»
Chiesi USA
175 Regency Woods Place, Suite 600, Cary, NC 27518 PP-MULTI-0024 V41.0See details»
Chiesi Group - LinkedIn
Chiesi Group | 208,259 followers on LinkedIn. Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in …See details»
History | Chiesi Farmaceutici S.p.A.
Bridging Health Gaps . 2005. Chiesi's mission to foster health equity globally took shape with the establishment of the Chiesi Foundation.The organization was founded with the goal of …See details»
Chiesi Canada Corp Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Chiesi Canada Corp of Woodbridge, ON. Get the latest business insights from Dun & Bradstreet.See details»
Chiesi: Industry-leading respiratory health, rare diseases, and ...
Nov 5, 2024 Chiesi is an international, research-oriented biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and …See details»
Chiesi Clinical Trials | Connecting Patients, Caregivers
Discover Chiesi Clinical Trials—your gateway to exploring innovative treatments. Learn how our clinical research platform connects patients, caregivers, and healthcare professionals with …See details»
Global corporate development | Chiesi Global corporate …
USA Chiesi USA, Inc. HQ 175 Regency Woods Place Suite 600 Cary, NC 27518See details»
Chiesi Global Rare Diseases Announces Collaboration with the NAMI
BOSTON, April 4, 2023 - Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, …See details»
Chiesi backs growth plans with a €430m new plant in Italy
Mar 28, 2025 Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at its site in Milan, extending its efforts to align its …See details»
New organisational order for the Chiesi Foundation
Parma, May 3 2021 – On May 1 Maria Paola Chiesi was appointed President of the Chiesi Foundation, a non-profit organisation established in 2005 as an expression of the corporate …See details»